NCT06086899

Brief Summary

This study is a double blind, randomized controlled trail. condition/disease: radiating pain in the upper extremity. treatment/intervention: motion style acupuncture treatment

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 12, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 17, 2023

Completed
20 days until next milestone

Study Start

First participant enrolled

November 6, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

September 4, 2025

Status Verified

September 1, 2025

Enrollment Period

9 months

First QC Date

October 12, 2023

Last Update Submit

September 1, 2025

Conditions

Keywords

Motion Style Acupuncture TreatmentRadiating pain

Outcome Measures

Primary Outcomes (1)

  • Numeric Rating Scale(NRS) of radiating pain

    NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10. The participant is asked to report their leg pain and discomfort using NRS, where 0 indicates 'no pain or discomfort' and 10 indicates 'the most severe pain and discomfort imaginable'.

    Screening, Baseline(day2), day3, day4, day5, Discharge 1 day, 1month after enrollment, 3month after enrollment

Secondary Outcomes (7)

  • Location of Radiating pain

    Baseline(day2), day3, day4, day5, Discharge 1 day, 1month after enrollment, 3month after enrollment

  • VAS of Radiating pain

    Baseline(day2), day3, day4, day5, Discharge 1 day, 1month after enrollment, 3month after enrollment

  • C-SPINE MRI

    Taken within ±14 days of hospitalization

  • NRS of Neck pain

    Baseline(day2), day3, day4, day5, Discharge 1 day, 1month after enrollment, 3month after enrollment

  • NDI

    Baseline(day2), day5, Discharge 1 day, 1month after enrollment, 3month after enrollment

  • +2 more secondary outcomes

Study Arms (2)

Cervical motion style acupuncture treatment(Trapezius, Rhomboid, Scalene)

EXPERIMENTAL

The MSAT group recieved 3 sessions of MSAT; on second, third, fourth day after hospitalization. A trained doctor of Korean medicine with at least 3 years of clinical experience conducted the MSAT. The MSAT group were also treated with other Korean medical treatment everyday: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.

Procedure: Cervical motion style acupuncture treatment(Trapezius, Rhomboid, Scalene)Procedure: Korean medical treatment

Korean medical treatment

ACTIVE COMPARATOR

The control group were received Korean medical treatment everyday after hospitalization: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.

Procedure: Korean medical treatment

Interventions

Motion Style Acupuncture Treatment(MSAT) is a therapeutic technique using acupuncture needle created in Jaseng Hospital. This treatment involves patients with musculoskeletal pain to move the part of their body actively during acupuncture treatment under physicians' observation

Cervical motion style acupuncture treatment(Trapezius, Rhomboid, Scalene)

acupuncture treatment, chuna, pharmacoacupuncture, Korean herbal medicine

Cervical motion style acupuncture treatment(Trapezius, Rhomboid, Scalene)Korean medical treatment

Eligibility Criteria

Age19 Years - 69 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 19-69 years on the date they sign the consent form.
  • Patients who are suffered byradiating pain in the upper extremity that occurred within 3 days after traffic accident.
  • Patients who are hospitalized due to traffic accident.
  • Patients with NRS of radiating pain ≥ 5.
  • Patients who provide consent to participate in the trial and return the informed consent form.

You may not qualify if:

  • Patients with a specific serious disease that may cause radiating pain: malignancy, spondylitis, inflammatory spondylitis, etc.
  • Patients with progressive neurological deficits or with severe neurological symptoms.
  • Patients with medical history of cervical surgery or thoracic surgery within the last three weeks.
  • Patients who have radiating pain in upper extremity before the traffic accident.
  • Patients with a specific serious disease that may interfere with the interpretation of the therapeutic effects or results: malignancy, spondylitis, inflammatory spondylitis, etc.
  • Patients who are taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect the results of the study.
  • If acupuncture is inadequate or unsafe: patients with hemorrhagic, receiving anticoagulants, severe diabetes and cardiovascular disease.
  • Patients who are pregnant or planning to become pregnant.
  • Patients who are participated in clinical trials other than observational studies without therapeutic intervention.
  • Patients who are difficult to complete the research participation agreement.
  • Other patients whose participation in the trial is judged by a researcher to be problematic.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jaseng Hospital of Korean Medicine

Seoul, Gangnam-Gu, 135-896, South Korea

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • In-Hyuk Ha, phD

    Jaseng Medical Foundation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A Pragmatic randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 12, 2023

First Posted

October 17, 2023

Study Start

November 6, 2023

Primary Completion

July 30, 2024

Study Completion

December 30, 2024

Last Updated

September 4, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations